These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12391383)

  • 1. Treatment of Guillain-Barré syndrome.
    Winer JB
    QJM; 2002 Nov; 95(11):717-21. PubMed ID: 12391383
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Guillain-Barré Syndrome].
    Nomura K
    Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome (GBS).
    Pithadia AB; Kakadia N
    Pharmacol Rep; 2010; 62(2):220-32. PubMed ID: 20508277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Guillain-Barré syndrome.
    McNair ND
    J Infus Nurs; 2013; 36(6):397-400. PubMed ID: 24202119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barre syndrome in children.
    Tabarki-Melaiki B
    Neurosciences (Riyadh); 2011 Apr; 16(2):174-5. PubMed ID: 21427674
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
    Mehndiratta MM; Chowdhury D; Goel V
    J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Odaka M
    Nihon Rinsho; 2004 May; 62 Suppl 5():491-5. PubMed ID: 15197970
    [No Abstract]   [Full Text] [Related]  

  • 8. A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method.
    Kesici S; Tanyıldız M; Yetimakman F; Bayrakci B
    J Child Neurol; 2019 Apr; 34(5):277-283. PubMed ID: 30696330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome.
    Li HF; Xie YC
    Lancet Neurol; 2008 Dec; 7(12):1081-2; author reply 1083-5. PubMed ID: 19007731
    [No Abstract]   [Full Text] [Related]  

  • 10. The challenges of managing and treating Guillain-Barré syndrome during the acute phase.
    Atkinson SB; Carr RL; Maybee P; Haynes D
    Dimens Crit Care Nurs; 2006; 25(6):256-63. PubMed ID: 17122655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome in general practice: clinical features suggestive of early diagnosis.
    Head VA; Wakerley BR
    Br J Gen Pract; 2016 Apr; 66(645):218-9. PubMed ID: 27033501
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunotherapy of Guillain-Barré syndrome.
    Restrepo-Jiménez P; Rodríguez Y; González P; Chang C; Gershwin ME; Anaya JM
    Expert Opin Biol Ther; 2018 Jun; 18(6):619-631. PubMed ID: 29681203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world treatment of adult patients with Guillain-Barré syndrome over the last two decades.
    Rath J; Zulehner G; Schober B; Grisold A; Krenn M; Cetin H; Zimprich F
    Sci Rep; 2021 Sep; 11(1):19170. PubMed ID: 34580356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel Therapeutic Interventions in Guillain-Barré Syndrome: Review and Future Perspective].
    Misawa S
    Brain Nerve; 2015 Nov; 67(11):1421-8. PubMed ID: 26560957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling Guillain-Barré syndrome.
    Castro MC
    Nurs Manage; 2010 Aug; 41(8):36-9; quiz 39-40. PubMed ID: 20671533
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of immune-mediated inflammatory neuropathies.
    Hadden RD; Hughes RA
    Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis.
    Nagpal S; Benstead T; Shumak K; Rock G; Brown M; Anderson DR
    J Clin Apher; 1999; 14(3):107-13. PubMed ID: 10540364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin".
    Buenz EJ
    J Clin Neurosci; 2009 Aug; 16(8):1110; author reply 1111. PubMed ID: 19467870
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guillain-Barré syndrome: epidemiological, clinical and therapeutic insight].
    Raphaël JC; Sharshar T
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S35-40. PubMed ID: 10896987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.